Courtesy, Agencies News
Zambia, Ghana, Burundi And The Democratic Republic Of Congo have licensed Ervebo,an EBOLA Vaccine produced by Merck’s for use.
The Vaccine pre-qualified by the World Health Organization according to a press release is expected in additional Countries in the coming weeks.
By this latest development, the manufacturer is to distribute the Vaccine enmass to African Countries at risk of the disease outbreak
The Vaccine according to experts has shown to be safe and protective against the Zaire Strain of Ebola Virus.
The Vaccine is said to consist of a vesicular stomatitis Virus which is an animal virus that causes flu like illness in humans.